Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Questionnaire.
BACKGROUND
Up to 40% of childhood cancer survivors may experience neurocognitive impairment in 1 or more specific domains. As such, regular monitoring has been recommended for patients exposed to cranial irradiation and/or antimetabolite chemotherapy. This study reports the results of a questionnaire developed to identify those survivors who may be experiencing neurocognitive problems.


METHODS
Participants for this study were 7121 members of the Childhood Cancer Survivor Study cohort (6739 survivors and 382 siblings). These participants completed a new neurocognitive questionnaire designed to assess functions commonly affected by cancer therapy, as well as a standard measure of emotional functioning. A measure of cognitive and emotional functioning was also completed on a subset of the patients roughly 7 years before the current questionnaire. Responses to the questionnaires among subgroups of survivors were then analyzed to examine the reliability and validity of the new neurocognitive questionnaire.


RESULTS
Four reliable factors were identified that assessed task efficiency, emotional regulation, organization, and memory skills. These neurocognitive factors accurately discriminated survivors who were at "high risk" for neurocognitive dysfunction, because of neurologic abnormalities or a history of intensive focal cranial irradiation, from healthy "low-risk" survivors and siblings.


CONCLUSIONS
The questionnaire demonstrated excellent reliability, as well as construct and discriminative validity. It appears to be a practical and efficient tool for monitoring neurocognitive outcomes in adult survivors of pediatric cancer.
Krull
Kevin R
KR
Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA. kevin.krull@stjude.org
Gioia
Gerard
G
Ness
Kirsten K
KK
Ellenberg
Leah
L
Recklitis
Christopher
C
Leisenring
Wendy
W
Huang
Sujuan
S
Stovall
Marilyn
M
Robison
Leslie L
LL
Zeltzer
Lonnie
L
D000328:Adult; D017668:Age of Onset; D002648:Child; D003072:Cognition Disorders / Q000175:diagnosis* / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D015203:Reproducibility of Results; D012307:Risk Factors; D011795:Surveys and Questionnaires; D017741:Survivors
Med Hypotheses. 2007;69(1):67-9
17368750
Arch Clin Neuropsychol. 2000 Oct;15(7):603-30
14590198
ASAIO J. 2005 Nov-Dec;51(6):764-8
16340365
J Int Neuropsychol Soc. 2007 Sep;13(5):729-46
17511896
J Clin Hypertens (Greenwich). 2005 Oct;7(10):598-604
16227762
J Neurol Sci. 2004 Nov 15;226(1-2):25-9
15537514
J Clin Oncol. 2007 Aug 20;25(24):3649-56
17704415
Pediatr Rehabil. 1997 Apr-Jun;1(2):63-76
9689241
Pediatr Blood Cancer. 2007 Jul;49(1):65-73
16628558
J Head Trauma Rehabil. 2005 Nov-Dec;20(6):512-26
16304488
Ment Retard Dev Disabil Res Rev. 2006;12(3):184-91
17061287
Psychiatry Res. 1989 May;28(2):193-213
2748771
Acta Psychiatr Scand. 2007 Aug;116(2):129-36
17650275
Eur Neurol. 2007;57(1):39-46
17108694
Med Pediatr Oncol. 2002 Apr;38(4):229-39
11920786
Neuropsychologia. 2007 May 15;45(9):2016-24
17379262
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
8433390
Cogn Neuropsychiatry. 2005 Nov;10(5):379-99
16571468
J Clin Exp Neuropsychol. 2006 Apr;28(3):325-40
16618623
Psychol Sci. 2007 Oct;18(10):893-900
17894607
Med Care. 1999 Feb;37(2):126-39
10024117
Int J Geriatr Psychiatry. 2005 Sep;20(9):848-54
16116585
J Clin Oncol. 1991 Aug;9(8):1348-56
2072138
Epilepsy Behav. 2005 Nov;7(3):438-46
16091308
J Clin Epidemiol. 1988;41(10):949-58
3057117
J Pediatr Hematol Oncol. 2000 May-Jun;22(3):206-13
10864051
BMJ. 1992 Jun 6;304(6840):1491-4
1611375
Arch Pediatr Adolesc Med. 2007 Aug;161(8):798-806
17679663
J Clin Oncol. 2006 Aug 20;24(24):3858-64
16921038
J Int Neuropsychol Soc. 2005 Jul;11(4):477-81
16209428
J Am Geriatr Soc. 2005 Jan;53(1):103-7
15667385
Psychol Assess. 2006 Mar;18(1):22-32
16594809
Med Pediatr Oncol. 1998;Suppl 1:34-40
9659944
Lancet Oncol. 2004 Jul;5(7):399-408
15231246
Brain. 2006 Aug;129(Pt 8):2148-57
16870885
J Neurooncol. 2005 May;72(3):245-53
15937648
Eur J Cancer. 1997 Jun;33(7):1025-30
9376182
AJNR Am J Neuroradiol. 2005 May;26(5):1263-9
15891195
Epilepsy Behav. 2006 Sep;9(2):339-44
16870509
J Abnorm Child Psychol. 2006 Dec;34(6):841-52
17051435